Android app Apple app link

BTIG Maintains a Buy on Apogee Therapeutics (APGE)

By Yahoo! Finance   |   1 month ago
BTIG Maintains a Buy on Apogee Therapeutics (APGE)

Apogee Therapeutics Inc. (NASDAQ:APGE) is a top healthcare stock with high potential. Analyst Julian Harrison maintains a Buy rating, citing optimism in the company's APG777 treatment for asthma and dermatitis. Positive clinical data indicates significant upside potential.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.